Evidence map›Paper›PMID 36745602›Full record

ArticlePloS one2023

Action potential metrics and automated data analysis pipeline for cardiotoxicity testing using optically mapped hiPSC-derived 3D cardiac microtissues.

Arvin H Soepriatna, Allison Navarrete-Welton, Tae Yun Kim, Mark C Daley, Peter Bronk, Celinda M Kofron, Ulrike Mende, Kareen L K Coulombe, Bum-Rak Choi

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Arvin H SoepriatnaCenter for Biomedical Engineering, School of Engineering, Brown University, Providence, Rhode Island, United States of America.ORCID 0000-0002-7756-1389
Allison Navarrete-WeltonCardiovascular Research Center, Cardiovascular Institute, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.ORCID 0000-0002-3124-5743
Tae Yun KimCardiovascular Research Center, Cardiovascular Institute, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.
Mark C DaleyCenter for Biomedical Engineering, School of Engineering, Brown University, Providence, Rhode Island, United States of America.ORCID 0000-0002-7236-5215
Peter BronkCardiovascular Research Center, Cardiovascular Institute, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.
Celinda M KofronCenter for Biomedical Engineering, School of Engineering, Brown University, Providence, Rhode Island, United States of America.
Ulrike MendeCardiovascular Research Center, Cardiovascular Institute, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.ORCID 0000-0002-3362-6072
Kareen L K CoulombeCenter for Biomedical Engineering, School of Engineering, Brown University, Providence, Rhode Island, United States of America.ORCID 0000-0001-6664-339X
Bum-Rak ChoiCardiovascular Research Center, Cardiovascular Institute, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.ORCID 0000-0001-7319-3219

Funding

Human 3D Microtissues for Toxicity Testing via Integrated Imaging, Molecular and Functional AnalysesU01ES028184 · NIEHS · BROWN UNIVERSITY · PI BOEKELHEIDE, KIM, MORGAN, JEFFREY R · 2017 to 2021
$3.8M
Warren Alpert Medical School Basic Translational ResearchT35HL094308 · NHLBI · BROWN UNIVERSITY · PI Thomas Benedict Bartnikas, Brittany Star Hampton · 2009 to 2026
$808k
NHLBI NIH HHS T35 HL094308NIEHS NIH HHS U01 ES028184
6 · The paper itself

Abstract

Recent advances in human induced pluripotent stem cell (hiPSC)-derived cardiac microtissues provide a unique opportunity for cardiotoxic assessment of pharmaceutical and environmental compounds. Here, we developed a series of automated data processing algorithms to assess changes in action potential (AP) properties for cardiotoxicity testing in 3D engineered cardiac microtissues generated from hiPSC-derived cardiomyocytes (hiPSC-CMs). Purified hiPSC-CMs were mixed with 5-25% human cardiac fibroblasts (hCFs) under scaffold-free conditions and allowed to self-assemble into 3D spherical microtissues in 35-microwell agarose gels. Optical mapping was performed to quantify electrophysiological changes. To increase throughput, AP traces from 4x4 cardiac microtissues were simultaneously acquired with a voltage sensitive dye and a CMOS camera. Individual microtissues showing APs were identified using automated thresholding after Fourier transforming traces. An asymmetric least squares method was used to correct non-uniform background and baseline drift, and the fluorescence was normalized (ΔF/F0). Bilateral filtering was applied to preserve the sharpness of the AP upstroke. AP shape changes under selective ion channel block were characterized using AP metrics including stimulation delay, rise time of AP upstroke, APD30, APD50, APD80, APDmxr (maximum rate change of repolarization), and AP triangulation (APDtri = APDmxr-APD50). We also characterized changes in AP metrics under various ion channel block conditions with multi-class logistic regression and feature extraction using principal component analysis of human AP computer simulations. Simulation results were validated experimentally with selective pharmacological ion channel blockers. In conclusion, this simple and robust automated data analysis pipeline for evaluating key AP metrics provides an excellent in vitro cardiotoxicity testing platform for a wide range of environmental and pharmaceutical compounds.

Indexed as

Action PotentialsCardiotoxicityInduced Pluripotent Stem CellsHumansIon ChannelsMyocytes, CardiacIon Channels

Identifiers

PMID36745602
PMCPMC9901774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.